Ownership history in Qube Research & Technologies Ltd · 9 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,588 | -1,256 | -32.7% | 0.00% | $1.2M | $458.66 |
| 2025 Q2 | ADDED | 3,844 | +2,686 | +232.0% | 0.00% | $1.2M | $302.64 |
| 2024 Q1 | ADDED | 1,158 | +1,125 | +3409.1% | 0.00% | $309K | $267.04 |
| 2023 Q4 | REDUCED | 33 | -10,294 | -99.7% | 0.00% | $8K | $231.38 |
| 2022 Q2 | ADDED | 10,327 | +3,963 | +62.3% | 0.01% | $739K | $71.58 |
| 2021 Q2 | ADDED | 6,364 | +2,473 | +63.6% | 0.01% | $620K | $97.41 |
| 2021 Q1 | REDUCED | 3,891 | -3,202 | -45.1% | 0.01% | $455K | $116.97 |
| 2020 Q3 | ADDED | 7,093 | +5,243 | +283.4% | 0.01% | $842K | $118.73 |
| 2020 Q2 | INITIATED | 1,850 | — | — | 0.00% | $210K | $113.25 |
As of 2025 Q4 — sorted by position size